A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis

Brad H. Rovin, RF van Vollenhoven, Cynthia Aranow, Carrie Wagner, Robert Gordon, Yanli Zhuang, Stanley Belkowski, Benjamin Hsu

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2174-2183
JournalArthritis & rheumatology
Issue number9
Publication statusPublished - Sep 2016

Cite this